Glucocorticoids and COVID-19
S Bruscoli, PG Puzzovio, M Zaimi, K Tiligada… - Pharmacological …, 2022 - Elsevier
Abstract Coronavirus Disease 19 (COVID-19) is associated with high morbidity and mortality
rates globally, representing the greatest health and economic challenge today. Several …
rates globally, representing the greatest health and economic challenge today. Several …
[HTML][HTML] The Role of Glucocorticoids in the Management of COVID-19
VI Alexaki, H Henneicke - Hormone and Metabolic Research, 2021 - thieme-connect.com
Coronavirus disease 2019 (COVID-19), caused by an infection with the novel coronavirus
SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health …
SARS-CoV-2, has resulted in a global pandemic and poses an emergency to public health …
A critical evaluation of glucocorticoids in the management of severe COVID-19
C Solinas, L Perra, M Aiello, E Migliori… - Cytokine & growth factor …, 2020 - Elsevier
The viral infection by SARS-CoV-2 has irrevocably altered the life of the majority of human
beings, challenging national health systems worldwide, and pushing researchers to rapidly …
beings, challenging national health systems worldwide, and pushing researchers to rapidly …
Glucocorticoid therapy in COVID-19
F Amati, A Tonutti, J Huston… - Seminars in respiratory …, 2023 - thieme-connect.com
Coronavirus disease 2019 (COVID-19) pneumonia caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has resulted in significant mortality in pandemic …
syndrome coronavirus 2 (SARS-CoV-2) has resulted in significant mortality in pandemic …
[HTML][HTML] Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis
Background Glucocorticoids are widely used in the treatment of various pulmonary
inflammatory diseases, but they are also often accompanied by significant adverse …
inflammatory diseases, but they are also often accompanied by significant adverse …
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
Prolonged, low-dose glucocorticoids (GCs) have shown the highest efficacy among
pharmacological and non-pharmacological treatments for COVID-19. Despite the World …
pharmacological and non-pharmacological treatments for COVID-19. Despite the World …
[HTML][HTML] Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience
Y Hu, T Wang, Z Hu, X Wang, Z Zhang, L Li… - Biomedicine & …, 2020 - Elsevier
The aim of the present study was to identify the clinical efficacy of glucocorticoid therapy on
the treatment of patients with Coronavirus Disease 2019 (COVID-19) pneumonia. Clinical …
the treatment of patients with Coronavirus Disease 2019 (COVID-19) pneumonia. Clinical …
Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs
X Ye, Y Li, F Luo, Z Xu, K Kasimu, J Wang, P Xu… - Clinical and …, 2024 - Springer
In the realm of acute respiratory infections, coronavirus disease-19 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a global public …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a global public …
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom …
syndrome coronavirus 2 (SARS-CoV-2), is characterized by a wide spectrum of symptom …
Corticosteroids for COVID-19: worth it or not?
Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …